Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/POLYPID-LTD-42452430/news/PolyPid-Announces-500th-Patient-Enrolled-in-SHIELD-I-Phase-3-Clinical-Trial-of-D-PLEX100-in-Abdomi-37065802/?utm_source=whatsapp&utm_medium=social&utm_campaign=share